The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities ...

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...

Roche has now beat Merck and Bristol Myers to market with its under-the-skin immunotherapy. Elsewhere, Sanofi bought into radiopharmaceuticals and Mene Pangalos joined Biogen's board.

DelveInsight's Nontuberculous Mycobacterial Infection Market Insights report includes a comprehensive understanding of ...

Carillon Eagle Growth & Income Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the second quarter 2024 investor letter. AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other 52-week high stocks. The U.S. stock market has been on a roll, with major indices ...

Running commands in the background is a powerful feature in Linux that allows users to execute long-running processes without tying up the terminal. This capability is particularly useful for ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that add up to a wide moat. The strong replenishment of new drugs ...

AstraZeneca and Ionis Pharmaceuticals are also teamed up ... Alnylam tested vutrisiran in patients receiving background ...

Qiagen and AstraZeneca are expanding their diagnostics partnership, with plans to explore the use of genomic profiling in chronic diseases beyond cancer. The long-time collaborators, which ...

AstraZeneca has beaten all healthcare-focused ETFs. The stock is up by over 27% this year, helped by its oncology business. It has gotten highly overbought, meaning that a pullback is coming ...